Clinical Trial Update: Genentech Validation Tool for Pulmonary Fibrosis

View source ↗

Summary

A clinical trial update indicates a Genentech validation tool for pulmonary fibrosis is being evaluated for interstitial lung disease, with the study currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Fibrosis

Snippet

Sponsor: Columbia University | Conditions: Interstitial Lung Disease | Status: ACTIVE_NOT_RECRUITING